The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO Sarcoma & GIST 2022 | The significance of interactive and educational meetings for sarcoma

Name: The significance of interactive and educational meetings for sarcoma
Uploaded: 2022-02-09T00:00:00Z
Duration: 1 min 4 s
Description: Robin Jones, MBBS, MRCP, MD, The Royal Marsden NHS Foundation Trust, London, UK, talks on the rarity and heterogeneity of sarcoma, explaining the importance of interactive and educational meetings as an invaluable resource for younger doctors to aid in comprehension of this complex disease. This interview took place during the European Society for Medical Oncology (ESMO) Sarcoma & GIST Symposium.

Robin Jones • 9 Feb 2022

ESMO Sarcoma & GIST 2022

Gastrointestinal Cancer Sarcoma

Robin Jones, MBBS, MRCP, MD, The Royal Marsden NHS Foundation Trust, London, UK, talks on the rarity and heterogeneity of sarcoma, explaining the importance of interactive and educational meetings as an invaluable resource for younger doctors to aid in comprehension of this complex disease. This interview took place during the European Society for Medical Oncology (ESMO) Sarcoma & GIST Symposium.